NMTC News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

NM

Mkt Cap

$8.8M

Volume

93.34K

Loading chart

NM

NMTCNeuroOne Medical Technologies Corporation Common Stock

NMTC

Pay with—

Available Balance0.00

NM

Mkt Cap

$9.5M

Volume

93.34K

Next Earnings

N/A

Chart Financials Earnings News About Insider Filings

NeuroOne Q3 Revenue Jumps 105 PercentNeuroOne Medical Technologies reported strong Q3 2025 performance with 105% product revenue growth, improved gross margins, and promising clinical milestones for its OneRF ablation system, including the first patient achieving 12-month seizure freedom.The Motley Fool · Aug 14, 2025

NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern TimeNeuroOne Medical Technologies Corporation will release its fiscal first quarter 2025 financial results on February 12, 2025, and host an investor conference call to discuss the results and provide a corporate update.GlobeNewswire Inc. · Feb 5, 2025

NeuroOne faces Nasdaq delisting over share price woe - Investing.comNeuroOne Medical Technologies Corporation has been notified by Nasdaq that it is not in compliance with the minimum bid price requirement, and faces delisting if it fails to regain compliance within the grace period.Investing.com · Jul 13, 2024

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF AblationICD-10-PCS code for first to market, FDA-cleared thin-film, sEEG-guided RF ablation system effective October 1, 2024GlobeNewswire Inc. · Jun 20, 2024

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateEDEN PRAIRIE, Minn., May 14, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces its operating results for the second quarter fiscal year 2024 ended March 31, 2024.GlobeNewswire Inc. · May 14, 2024

NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14EDEN PRAIRIE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call and webcast on May 14, 2024 at 4:30 PM Eastern Time to discuss financial results for its second quarter of fiscal year 2024 ended March 31, 2024, and provide a corporate update.GlobeNewswire Inc. · May 10, 2024

NeuroOne® Announces First Implant of OneRF™ Ablation ElectrodesFirst to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature controlGlobeNewswire Inc. · Apr 9, 2024

NeuroOne® to Participate in the 36th Annual Roth ConferenceEDEN PRAIRIE, Minn., March 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced its participation in the 36th Annual Roth Conference being held March 17-19, 2024 in Dana Point, California. Chief Executive Offer Dave Rosa and Chief Financial Officer Ron McClurg will host one-on-one meetings with institutional investors and analysts on Monday, March 18th and Tuesday, March 19th.GlobeNewswire Inc. · Mar 8, 2024

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders today announced that, effective February 23, 2024, the Compensation Committee of the Board of Directors approved an equity award under the NeuroOne Medical Technologies Corporation 2021 Inducement Plan (the “Inducement Plan”), as a material inducement to one individual entering into employment with the Company. The equity award was approved in accordance with Nasdaq Listing Rule 5635(c)(4), which also requires a public announcement of awards that are not made under a stockholder approved equity plan.GlobeNewswire Inc. · Feb 23, 2024

NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateEDEN PRAIRIE, Minn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces its operating results for the first quarter fiscal year 2024 ended December 31, 2023.GlobeNewswire Inc. · Feb 13, 2024

to start trading

NM

NMTCNeuroOne Medical Technologies Corporation Common Stock

NMTC

Pay with—

Available Balance0.00

Your PositionYou don't own any NMTC yet.

Related Tickers

Earnings